717178009: Reslizumab (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with receptor antagonist mechanism of action (substance)\Substance with interleukin receptor antagonist mechanism of action (substance)\Substance with interleukin 5 receptor antagonist mechanism of action (substance)\Reslizumab
\Substance categorized by disposition\Immunomodulator\Substance with interleukin receptor antagonist mechanism of action (substance)\Substance with interleukin 5 receptor antagonist mechanism of action (substance)\Reslizumab

\Drug or medicament (substance)\Respiratory system agent (substance)\Reslizumab
\Drug or medicament (substance)\Immunologic agent (substance)\Substance with interleukin 5 receptor antagonist mechanism of action (substance)\Reslizumab
\Drug or medicament (substance)\Monoclonal antibody\Reslizumab

\Substance categorised by structure\Chemical\Chemical categorized by structure\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Amide and/or amide derivative\Substituted amide (substance)\Polypeptide\Protein\Antibody\Monoclonal antibody\Reslizumab

\Organic compound\Organic nitrogen compound\Amide and/or amide derivative\Substituted amide (substance)\Polypeptide\Protein\Antibody\Monoclonal antibody\Reslizumab

\Biological substance\Protein and/or protein derivative\Protein\Antibody\Monoclonal antibody\Reslizumab
\Biological substance\Immunologic substance\Antibody\Monoclonal antibody\Reslizumab
\Biological substance\Polypeptide\Protein\Antibody\Monoclonal antibody\Reslizumab

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2016. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Reslizumab	Is a	Respiratory system agent (substance)	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Reslizumab	Is a	agent d'anticorps monoclonal	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Reslizumab	Is a	Monoclonal antibody	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Reslizumab	Is a	Substance with interleukin 5 receptor antagonist mechanism of action (substance)	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Reslizumab	Has disposition	Interleukin 5 receptor antagonist	true	Inferred relationship	Existential restriction modifier (core metadata concept)

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing only reslizumab in parenteral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Reslizumab	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing reslizumab (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Reslizumab	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Reslizumab only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Reslizumab	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Reslizumab-containing product in parenteral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Reslizumab	Inferred relationship	Existential restriction modifier (core metadata concept)	1

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
3308594018	Reslizumab (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3308595017	Reslizumab	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3308594018	Reslizumab (substance)	en	Fully specified name	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
3308594018	Reslizumab (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3308595017	Reslizumab	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
3308595017	Reslizumab	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
373391000195114	reslizumab	it	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
837871000172119	reslizumab	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
837871000172119	reslizumab	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
373391000195114	reslizumab	it	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module